Search research articles
Contact Us
Filters
Showing results (521-530 of 554) with videos related to
Page
of 56
Sort By:
Organic Letters
|
July 1, 2005
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum
Wayne W Harding, Kevin Tidgewell, Matthew Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 2025
Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]
Caroline C Benoist, Leen H Kawas, Mingyan Zhu, et al.
Journal of Behavioral Education
|
June 14, 2013
A Preliminary Evaluation of Functional Communication Training Effectiveness and Language Preference When Spanish and English are Manipulated
Yaniz C Padilla Dalmau, David P Wacker, Jay W Harding, et al.
Annals of Emergency Medicine
|
August 5, 2020
"It's Gonna be a Lifeline": Findings From Focus Group Research to Investigate What People Who Use Opioids Want From Peer-Based Postoverdose Interventions in the Emergency Department
Karla D Wagner, Maria L Mittal, Robert W Harding, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 5, 2014
The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system
Caroline C Benoist, Leen H Kawas, Mingyan Zhu, et al.
Behavioural Brain Research
|
August 11, 2004
Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms
Anthony L Albiston, Eric S Pederson, Peta Burns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel
Deborah Toppmeyer, Andrew D Seidman, Michael Pollak, et al.
Behavioural Brain Research
|
August 19, 2006
Habituation of the head-shake response induces changes in brain matrix metalloproteinases-3 (MMP-3) and -9
John W Wright, Starla E Meighan, Eric S Murphy, et al.
Anti-Cancer Drugs
|
February 1, 1997
Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro
U A Germann, D Shlyakhter, V S Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma
Vivien H C Bramwell, Donald Morris, D Scott Ernst, et al.
Page
of 56
Search research articles
Search
Showing results (521-530 of 554) with videos related to
Sort By:
Page
of 56
Organic Letters
|
July 1, 2005
Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum
Wayne W Harding, Kevin Tidgewell, Matthew Schmidt, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 2025
Retraction notice to "The Procognitive and Synaptogenic Effects of Angiotensin IV-Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System" [J Pharmacol Exp Ther 351 (2014) 390-402]
Caroline C Benoist, Leen H Kawas, Mingyan Zhu, et al.
Journal of Behavioral Education
|
June 14, 2013
A Preliminary Evaluation of Functional Communication Training Effectiveness and Language Preference When Spanish and English are Manipulated
Yaniz C Padilla Dalmau, David P Wacker, Jay W Harding, et al.
Annals of Emergency Medicine
|
August 5, 2020
"It's Gonna be a Lifeline": Findings From Focus Group Research to Investigate What People Who Use Opioids Want From Peer-Based Postoverdose Interventions in the Emergency Department
Karla D Wagner, Maria L Mittal, Robert W Harding, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 5, 2014
The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system
Caroline C Benoist, Leen H Kawas, Mingyan Zhu, et al.
Behavioural Brain Research
|
August 11, 2004
Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms
Anthony L Albiston, Eric S Pederson, Peta Burns, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2002
Safety and efficacy of the multidrug resistance inhibitor Incel (biricodar; VX-710) in combination with paclitaxel for advanced breast cancer refractory to paclitaxel
Deborah Toppmeyer, Andrew D Seidman, Michael Pollak, et al.
Behavioural Brain Research
|
August 19, 2006
Habituation of the head-shake response induces changes in brain matrix metalloproteinases-3 (MMP-3) and -9
John W Wright, Starla E Meighan, Eric S Murphy, et al.
Anti-Cancer Drugs
|
February 1, 1997
Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro
U A Germann, D Shlyakhter, V S Mason, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 13, 2002
Safety and efficacy of the multidrug-resistance inhibitor biricodar (VX-710) with concurrent doxorubicin in patients with anthracycline-resistant advanced soft tissue sarcoma
Vivien H C Bramwell, Donald Morris, D Scott Ernst, et al.
Page
of 56